(S)-Amlodipine malate
    1.
    发明申请
    (S)-Amlodipine malate 审中-公开
    (S) - 麦芽灵碱苹果酸盐

    公开(公告)号:US20060035940A1

    公开(公告)日:2006-02-16

    申请号:US11082253

    申请日:2005-03-16

    IPC分类号: C07D211/82 A61K31/455

    CPC分类号: A61K31/455 C07D211/90

    摘要: One aspect of the present invention relates to optically pure (S)-amlodipine malate. Another aspect of the present invention relates to (rac)-amlodipine malate. In a preferred embodiment, the compound is optically pure (S)-amlodipine L-malate. Another aspect of the present invention relates to a pharmaceutical composition comprising optically pure (S)-amlodipine malate. Another aspect of the present invention relates to a method of preparing optically pure (S)-amlodipine malate, comprising admixing optically pure (S)-amlodipine with malic acid. Another aspect of the present invention relates to the various polymorphic and solvated forms of optically pure (S)-amlodipine malate. In another prefered embodiment the invention relates to polymorphic and solvated forms A-G. The present invention also relates to a method of preparing optically pure (S)-amlodipine malate, comprising combining a salt of optically pure (S)-amlodipine with a malate salt to give optically pure (S)-amlodipine malate. In a preferred embodiment, the malate salt is an optically pure L-malate salt.

    摘要翻译: 本发明的一个方面涉及光学纯的(S) - 麦草碱苹果酸盐。 本发明的另一方面涉及(外消旋) - 苹果酸麦草碱。 在优选的实施方案中,该化合物是光学纯的(S) - 氨氯地平L-苹果酸盐。 本发明的另一方面涉及一种药物组合物,其包含光学上纯的(S) - 氨氯地平苹果酸盐。 本发明的另一方面涉及一种制备旋光纯(S) - 马洛替灵苹果酸盐的方法,其包括将旋光纯(S) - 氨氯地平与苹果酸混合。 本发明的另一方面涉及光学纯(S) - 氨氯地平苹果酸盐的各种多晶型和溶剂化形式。 在另一个优选的实施方案中,本发明涉及多晶型和溶剂化形式A-G。 本发明还涉及一种制备光学纯的(S) - 氨氯地平苹果酸盐的方法,其包括将光学纯的(S) - 氨氯地平的盐与苹果酸盐组合以得到光学纯的(S) - 氨氯地平苹果酸盐。 在优选的实施方案中,苹果酸盐是光学上纯的L-苹果酸盐。

    (S)-amlodipine malate
    2.
    发明申请
    (S)-amlodipine malate 审中-公开
    (S) - 氨氯地平苹果酸盐

    公开(公告)号:US20060030602A1

    公开(公告)日:2006-02-09

    申请号:US11082252

    申请日:2005-03-16

    IPC分类号: A61K31/455

    CPC分类号: A61K31/455 C07D211/90

    摘要: One aspect of the present invention relates to optically pure (S)-amlodipine malate. Another aspect of the present invention relates to (rac)-amlodipine malate. In a preferred embodiment, the compound is optically pure (S)-amlodipine L-malate. Another aspect of the present invention relates to a pharmaceutical composition comprising optically pure (S)-amlodipine malate. Another aspect of the present invention relates to a method of preparing optically pure (S)-amlodipine malate, comprising admixing optically pure (S)-amlodipine with malic acid. Another aspect of the present invention relates to the various polymorphic and solvated forms of optically pure (S)-amlodipine malate. In another prefered embodiment the invention relates to polymorphic and solvated forms A-G. The present invention also relates to a method of preparing optically pure (S)-amlodipine malate, comprising combining a salt of optically pure (S)-amlodipine with a malate salt to give optically pure (S)-amlodipine malate. In a preferred embodiment, the malate salt is an optically pure L-malate salt.

    摘要翻译: 本发明的一个方面涉及光学纯的(S) - 麦草碱苹果酸盐。 本发明的另一方面涉及(外消旋) - 苹果酸麦草碱。 在优选的实施方案中,该化合物是光学纯的(S) - 氨氯地平L-苹果酸盐。 本发明的另一方面涉及一种药物组合物,其包含光学上纯的(S) - 氨氯地平苹果酸盐。 本发明的另一方面涉及一种制备旋光纯(S) - 马洛替灵苹果酸盐的方法,其包括将旋光纯(S) - 氨氯地平与苹果酸混合。 本发明的另一方面涉及光学纯(S) - 氨氯地平苹果酸盐的各种多晶型和溶剂化形式。 在另一个优选的实施方案中,本发明涉及多晶型和溶剂化形式A-G。 本发明还涉及一种制备光学纯的(S) - 氨氯地平苹果酸盐的方法,其包括将光学纯的(S) - 氨氯地平的盐与苹果酸盐组合以得到光学纯的(S) - 氨氯地平苹果酸盐。 在优选的实施方案中,苹果酸盐是光学上纯的L-苹果酸盐。